Collectively, these updates signal a definitive shift in regulatory expectations: Regulators are no longer only asking whether documentation exists. They are looking at whether product, quality, regulatory, supplier, risk, and post-market data maintain a consistent narrative.
Blog
White Paper: The Magic Combo: RPA and AI Agents in Pharma Supply Chains
Explore why pharma supply chains should build RPA foundations before scaling AI agents, with a practical maturity model for automation before autonomy.
DSCSA Exception Handling Playbook: Workflows, Queues, SLAs, and Escalation Paths
A practical DSCSA exception handling playbook covering triage workflows, queue design, SLA targets, escalation paths, and the roles that make investigations resolve on time.
How to Run a DSCSA Traceability Fire Drill
A step-by-step guide to running a DSCSA traceability fire drill - from suspect product identification through investigation, FDA notification, and resolution - before a real event tests your readiness.
AI Readiness in Pharma Operations: The Minimum Data Foundation Required Before AI Can Deliver Value
AI readiness in pharma starts with trusted data. Learn the minimum foundation needed before AI can improve operations, quality, and supply chain decisions.
